We extended this analysis to another tumor cell line (the human acute myeloid leukemia cell line MOLM13) that is growth resistant with the SHP2 inhibitor SHP099 after KO of the INPPL1 or MAP4K5 genes (7) (GSE218491, GSE21223). This evidence concerns the gene INPPL1 and neoplasm.